UK Takes More Action To Fly In No-Deal Brexit Drug Supplies
Executive Summary
In the latest move in its no-deal Brexit preparations, the UK is offering a contract for suppliers to provide an “uninterrupted supply of medicines and medical products,” including temperature controlled and time-sensitive medicines.
You may also be interested in...
Coronavirus Notebook: WHO OKs Bharat’s Covaxin, AZ Pulls Swiss Vaxzevria Filing
The US FDA has rejected an emergency use authorization application for NRx Pharmaceuticals’ Zyesami (aviptadil) for use in COVID-19 patients with respiratory failure. The UK has revamped its emergency delivery service for drugs that experience shortages as a result of the pandemic and other factors.
UK Signs Three More No-Deal Brexit Drug Transport Contracts
Efforts to ensure that supplies of medicines continue to flow if the UK leaves the EU without a deal have been stepped up with the announcement of three contracts to provide an express delivery service for urgently needed products.
Will Pharma Firms Bear Cost Of UK Govt’s Latest No-Deal Brexit Supply Plans?
Life science companies are uneasy over the government’s latest proposals for emergency medical supplies to the UK if the country leaves the EU without a deal.